TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03114046

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lower extremity Constraint-induced movement therapy(LE-CIMT)
Description: Both phases (A and B) will last 10 weekdays, and during baseline and treatment phases, the data will be collected on 5 different odd days. Considering the long period of data collection. During the baseline phase, no assessment will be administered on even days. The treatment will be delivered daily, along 10 weekdays, 3.5 hours per day. The motor training will be delivered during 3 hours and 30 minutes will be allocated to the administration of the TP.~Both caregivers and participants will be individually interviewed before and after treatment.
Study: NCT06120062

Intervention type: OTHER
Intervention: swaddled
Description: the 1st experimental group were swaddled

Intervention type: OTHER
Intervention: mother's breast milk odor
Description: the 2nd experimental group were made to inhale mother's breast milk odor

Intervention type: OTHER
Intervention: both swaddled and made to inhale mother's breast milk odor
Description: the 3rd experimental group were both swaddled and made to inhale mother's breast milk odor

Intervention type: OTHER
Intervention: No procedure
Description: No procedure was applied to the infants in the control group.
Study: NCT02143674

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Muscle stretching and Strength Training
Description: Each step of stretching on specific muscles was repeated three times by keeping the posture for 30 seconds, (Arnold and Kokkonen, 2007; Toraman A, Yildirim. 2010; Dai, Ware, Giuliani, 2012; Duque et al., 2013; Granacher et al., 2013). The Pectoral, Quadriceps, Paraspinal, Abdominal and Ischial tibial and sural triceps muscles were elongated.~Strength Training Muscle strengthening was performed using weights and dumbbells. The training load individually determined through the test of strength with 10 repetitions maximum. The load was reevaluated four weeks of training. The Abdominal, Paraspinal, Quadriceps and Posterior thigh muscles (hamstrings) were submitted to the intervention protocol.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educated about physical exercises
Study: NCT03172793

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Telavancin Injection
Description: Receive 3 doses of telavancin as described in arm/groups, followed by collection of blood for pharmacokinetic analyses.
Study: NCT02440997

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: aromatherapy
Study: NCT03172793

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Telavancin Injection
Description: Receive 3 doses of telavancin as described in arm/groups, followed by collection of blood for pharmacokinetic analyses.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Telavancin Injection
Description: Receive 3 doses of telavancin as described in arm/groups, followed by collection of blood for pharmacokinetic analyses.
Study: NCT04643730

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupressure methods
Description: Acupressure on the KI3 and St36 points applied to the babies in the acupressure group for a total of 7 minutes before the heel prick

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Foot Reflexology Methods
Description: Foot reflexology was applied to the babies in the foot reflexology group for a total of 7 minutes before the heel prick
Study: NCT02440997

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: foot bath

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: foot bath
Study: NCT01228539

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TARGET (Trauma Affect Regulation)
Description: TARGET teaches a skill sequence for affect regulation and social/interpersonal information processing.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Prolonged Exposure
Description: Cognitive behavior therapy with trauma memory exposure
Study: NCT02759380

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Phytoestrogen-rich foods
Description: The patients will be given a package containing food with a high amount of phytoestrogens (≥100 mg isoflavonoids and ≥100 mg lignans) that are to be consumed daily. The food-package contains 30 grams of flaxseed, 25 grams of roasted soybeans and 50 grams of frozen green edamame beans to be consumed daily.
Study: NCT00890864

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Invitation for breast screening
Description: Invitation for breast screening to women in different age groups

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Invitation for breast screening
Description: Invitation for breast screening to women in different age groups
Study: NCT03478007

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intervention Technology
Description: Subjects will perform their exercises using the provided monitoring device. They will be able to contact the investigators with questions regarding the use of the monitoring device, however, no encouragement or coaching will be provided

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intervention Technology Plus Coaching
Description: Subjects will perform their exercises using the provided monitoring device. They will also be coached by a trained health coach through a weekly call.
Study: NCT04643730

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Grup
Description: No pre-application was made to the babies in the control group as a routine procedure.
Study: NCT03012217

Intervention type: OTHER
Intervention: Observational Study
Study: NCT02106221

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention
Description: Will receive payments based on achievement in meeting goals based on specified high value elements as well as effort.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Will receive payments based on achievement in meeting goals.
Study: NCT04340674

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telerehabilitation based on aerobic exercise
Description: To perform different whole body aerobic exercises moderately intense according to Borg scale.
Study: NCT01591395

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: laparoscopic total extraperitoneal hernia repair (single port vs. multiport)
Description: comparison of single port laparoscopic TEP and multiport laparoscopic TEP repair for adult inguinal hernia

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: laparoscopic total extraperitoneal hernia repair (single port vs. multiport)
Description: comparison of single port laparoscopic TEP and multiport laparoscopic TEP repair for adult inguinal hernia
Study: NCT02424331

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pursed Lips Breathing
Description: Pursed Lips Breathing for six minutes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quiet Breathing
Study: NCT04494373

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HS-20090
Description: A human IgG2 monoclonal antibody with affinity and specificity for human RANKL

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Xgeva®
Description: A human IgG2 monoclonal antibody with affinity and specificity for human RANKL
Study: NCT01015183

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zinc Sulfate
Description: Zinc Sulfate: 100 mg of zinc element, per day, bid for two weeks start with chemotherapy

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo: as the same of intervention group
Study: NCT05010382

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Implant placement surgery
Description: Under local anaesthesia, full-thickness mucoperiosteal flaps were elevated, the alveolar ridge measured, and a proper implant dimension (3.75 mm and 4.25 mm diameter; 8 mm, 10 mm and 11.5 mm length) and position selected. After site preparation, each patient was randomly allocated to the test or the control group. Patients in the test group received a modified implant design with the coronal third presenting a machined surface (hybrid surface (HS) group), while in the control group the same implant design with a titanium rough surface up to the implant shoulder was used (rough surface (RS) group). Implants were placed 1 mm sub-crestally. In the case of dehiscence or fenestrations around the implant, the patient was excluded from the study. Once inserted, healing abutments (ranging between 3 -5 mm) were placed, and flaps sutured around the abutments to allow for a transmucosal healing.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Implant placement surgery
Description: Under local anaesthesia, full-thickness mucoperiosteal flaps were elevated, the alveolar ridge measured, and a proper implant dimension (3.75 mm and 4.25 mm diameter; 8 mm, 10 mm and 11.5 mm length) and position selected. After site preparation, each patient was randomly allocated to the test or the control group. Patients in the test group received a modified implant design with the coronal third presenting a machined surface (hybrid surface (HS) group), while in the control group the same implant design with a titanium rough surface up to the implant shoulder was used (rough surface (RS) group). Implants were placed 1 mm sub-crestally. In the case of dehiscence or fenestrations around the implant, the patient was excluded from the study. Once inserted, healing abutments (ranging between 3 -5 mm) were placed, and flaps sutured around the abutments to allow for a transmucosal healing.
Study: NCT03791528

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Kinesio-taping treatment group
Description: In treatment group; Kinesio-taping 3 times at 5-day intervals, one of the fan-shaped cut bands, 2-3 inches above the SIJ, and the other below 2-3 inches below the SIJ, and crossed each other by 90 degrees. evaluated at baseline, the twentieth minute after application and on the 15th day by physical examination of the sacroiliac joint, visual analog scale, Modified Oswestry Low Back Pain Disability Questionnaire.
Study: NCT00611650

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: defined green tea catechin extract
Description: Given orally

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Given orally
Study: NCT02810223

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CART-19
Description: 2 to 5 x 10(6) autologous CART-19 transduced cells per kg body weight, with a maximum dose of 2.5 x 10(8) autologous CTL019 transduced cells via intravenous infusion.
Study: NCT02250027

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HL301 300mg capsule
Description: 2 capsules at once, 3 times a day, for 7 days

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 2 capsules at once, 3 times a day, for 7 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 2 capsules at once, 3 times a day, for 7 days
Study: NCT00503828

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Derris scandens Benth extracts
Description: Derris scandens Benth extracts (oral) 400 mg twice per day for 4 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: naproxen
Description: Naproxen 500 mg/day for 4 weeks
Study: NCT02250027

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 2 capsules at once, 3 times a day, for 7 days
Study: NCT00765024

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ivermectin
Description: single dose of 200 mcg/kg
Study: NCT03228043

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apatinib
Description: Apatinib combine with CAPEOX adjuvant chemotherapy for resectable colorectal
Study: NCT00765024

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ivermectin
Description: two single dose of 200mcg/kg in 2 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Albendazole
Description: Albendazole 7 days
Study: NCT00769574

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Biological analysis of biomarkers
Description: Biological analysis of biomarkers

Intervention type: OTHER
Group type: OTHER
Intervention: Biological analysis of biomarkers
Description: Biological analysis of biomarkers
Study: NCT03317132

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: IPS
Description: One year of IPS Support
Study: NCT02085915

Intervention type: OTHER
Group type: OTHER
Intervention: strip Peri Screen
Study: NCT01351246

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CBT Based Self-help Workbook + Counseling Telephone
Description: Over a period of 12 months parents work through 8 self-help booklets and additionally receive 14 counseling telephone calls. The intervention has a cognitive-behavioral foundation and is based on the therapy manual Therapy program for children with hyperactive and oppositional problem behavior THOP (Döpfner, Schürmann, \& Frölich, 2007) and the parent self-help book Wackelpeter and Trotzkopf: Help for parents of children with hyperkinetic and oppositional behavior (Döpfner, Schürmann, \& Lehmkuhl, 2006). Primary purpose of counseling telephone calls is to clarify contents of the booklets and support parents in managing their homework assignments accompanied with each booklet.
Study: NCT01805271

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Everolimus
Description: (5 or 10 mg/day, i.e. 1 or 2 tablets/day)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: (5 or 10 mg/day, i.e. 1 or 2 tablets/day)
Study: NCT04411524

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PD-1 antibody
Description: Before neo-CRT: 2 cycles of PD-1 antibody After neo-CRT: 3 cycles of PD-1 antibody

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: During neo-CRT: 625mg/m2 bid Monday-Friday per week

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan
Description: During neo-CRT: 80mg/m2 qw (UGT1A1\*28 6/6) or 65mg/m2 qw (UGT1A1\*28 6/7)

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Neoadjuvant Radiotherapy
Description: IMRT DT: 50Gy/25Fx
Study: NCT00137865

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: EGEN-001 (phIL-12-005/PPC)
Study: NCT02812355

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Heparin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Heparin
Study: NCT02449720

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine
Description: Intraperitoneal instillation and infusion

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine
Description: Intraperitoneal instillation and infusion

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 0.9% Saline
Description: Intraperitoneal instillation and infusion

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 0.9% Saline
Description: Intraperitoneal instillation and infusion
Study: NCT01600508

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Videoconference stoma care
Description: Stoma patients are randomized to videoconference stoma care or surgical outpatients clinic stoma care

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Videoconference stoma care
Description: Stoma patients are randomized to videoconference stoma care or surgical outpatients clinic stoma care
Study: NCT02015702

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: One-on-one physician training
Description: Physicians in the experimental arm were visited by a instructing physician at a computer while performing clinical duties who had observed others to identify best practices. Instructors watched subjects' work, looking for a specific tip that could be applied to the current work, then demonstrated the tip, and answered any questions the subject had about using or applying this new technique .

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual training
Description: Usual training included online e-modules, 12 hours of classroom time, practice in the EPIC Playground, user acceptability training classes,non-physician technical support on all of the floors, and a physician-only help line.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual training
Description: Usual training included online e-modules, 12 hours of classroom time, practice in the EPIC Playground, user acceptability training classes,non-physician technical support on all of the floors, and a physician-only help line.
Study: NCT01427062

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: experimental
Description: Subjects in the experimental group were trained the speed and amplitude of anticipatory postural adjustment during fall-prone activities and postural response to perturbation during walking. Training was provided with preparatory cues, computerized machines and treadmill.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: control
Description: Subjects in control group were provided with strength training of leg muscles using machines and during functional activities.
Study: NCT04007835

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anlotinib Hydrochloride
Description: anlotinib (12 mg orally daily for 14 days every 21 days cycle) combined with one of EGFR-TKIs
Study: NCT01577173

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MEHD7945A
Description: 1100 mg iv every 2 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: cetuximab
Description: 400 mg/m2 iv loading dose, followed by 250 mg/m2 weekly
Study: NCT03675763

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manual treatment
Description: Craniosacral therapy protocol.
Study: NCT02298517

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: incentive spirometry
Description: Incentive spirometry to flow and incentive spirometry to volume

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: inspiratory load equipment
Description: Threshold and Power breathe

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: inspiratory load equipment
Description: Threshold and Power breathe
Study: NCT01037374

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Preoperative assessment form
Description: (based on the american society of anesthesiologists)components of the form include: neck measurements; neck mobility; mallampati; wilson's test; pre-existing conditions; and predictions of difficult mask ventilation, supraglottic airway, laryngoscopy, intubation, and surgical airway.
Study: NCT02636764

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: exercise
Description: exercises designed with the objective of strengthening the musculature: flexor and extensor of the knee; extensor, abductor, lateral rotator of the hip.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise
Description: exercises designed with the objective of strengthening the musculature: flexor and extensor of the knee; extensor, abductor, lateral rotator of the hip.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: exercise
Description: exercises designed with the objective of strengthening the musculature: flexor and extensor of the knee; extensor, abductor, lateral rotator of the hip.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise
Description: exercises designed with the objective of strengthening the musculature: flexor and extensor of the knee; extensor, abductor, lateral rotator of the hip.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise
Description: exercises designed with the objective of strengthening the musculature: flexor and extensor of the knee; extensor, abductor, lateral rotator of the hip.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: interferential current
Description: The basic principle of Interferential Therapy (IFT) is to utilise the significant physiological effects of low frequency (\<250pps) electrical stimulation of nerves without the associated painful and somewhat unpleasant side effects sometimes associated with low frequency stimulation

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: short-wave diathermy
Description: Is a modality that produces deep heating via conversion of electromagnetic energy to thermal energy

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low level laser therapy
Description: Laser treatment in which the energy output is low enough so that the temperature of the treated tissue does not rise above 98.6°F (36.5° C) or normal body temperature.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Ultrasound therapy
Description: Ultrasound (US) is a form of mechanical energy, not electrical energy and therefore strictly speaking, not really electrotherapy at all but does fall into the Electro Physical Agents grouping.
Study: NCT01284179

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home Hypnotherapy
Description: Each session contains the following elements: (1) trance induction consisting of narrowing the focus of attention and eye-closure, (2) trance deepening through imagery, guided dissociation from the here-and-now and graded suggestions of change in mental state, (3) vivid guided imagery that engages all the senses and implies improved health, well-being and a sense of strength and personal power, (4) therapeutic suggestions and imagery, both direct and indirect, for enhanced chest comfort, overall physical comfort and mental well-being and immunity to discomfort, that is suggested will last beyond termination of the session and become more noticeable and permanent over time, and (5) trance termination through direct suggestions and counting.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Educational
Description: Educational recordings regarding FCP and FGIDs.
Study: NCT01325935

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Description: DAPT using aspirin 81 mg/day (minimal dose) and clopidogrel 75 mg/day should be conducted for 3 months (+ 30 days) after stenting.
Study: NCT01664039

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Travoprost 0.004% ophthalmic solution
Description: Ophthalmic solution without benzalkonium chloride (BAK), containing Polyquad® preservative

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bimatoprost 0.01% ophthalmic solution
Description: Ophthalmic solution containing benzalkonium chloride (BAK)
Study: NCT03117244

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise for Foot Strengthening
Description: Stabilization exercises of the longitudinal arch of the foot

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise for Foot Strengthening and Electrostimulation
Description: Exercise for the Strengthening of the Foot associated with Electrostimulation
Study: NCT00980941

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: soup with or without starch

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: soup with or without starch

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: soup with or without starch

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: soup with or without starch

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: soup with or without starch